Condition
Pharmacokinetic Study in Healthy Volunteers
Total Trials
8
Recruiting
0
Active
0
Completed
7
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 8 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
13%
1 trials in Phase 3/4
Results Transparency
0%
0 of 7 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (5)
P 1 (1)
P 4 (1)
Trial Status
Completed7
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (8)
Showing 8 of 8 trials
NCT06939608Not ApplicableCompletedPrimary
Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions
NCT06770491Phase 1Completed
A Phase 1 Study of Y-3 in US Healthy Volunteers.
NCT06840080Phase 4Completed
OEA and LipiSperse Metabolic Study
NCT06796374Not ApplicableNot Yet RecruitingPrimary
A Comparison of Fisetin Kinetics in Young and Old Adults
NCT06273241Not ApplicableCompletedPrimary
Impact of Food Intake on Berberine Kinetics
NCT05463003Not ApplicableCompletedPrimary
Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers
NCT05845931Not ApplicableCompletedPrimary
Sex Differences in Berberine Pharmacokinetics
NCT01326221CompletedPrimary
Single Dose Truvada in HIV-negative Men and Women
Showing all 8 trials